Sung is a partner in the Life Sciences Health Industry Group in the Washington D.C. office. Sung provides counsel to companies during both the pre-market and post-market phases of product life cycles. He guides companies in developing, distributing, and marketing FDA-regulated products and, when necessary, in responding to regulatory and administrative enforcement actions by federal and state agencies such as FDA, USDA, and state attorneys general offices. Sung understands the unique business landscape of FDA-regulated products, and provides practical advice that suits the needs of the client’s business.
In particular, Sung has counseled companies on designing regulatory routes for drug, medical device, food, dietary supplements, and cosmetic products; reviewed product labels and promotional materials; and worked with FDA district offices and headquarters to minimize any potential regulatory risk and to ensure the companies’ supply chain are not disrupted. As a bilingual attorney who has worked with many international companies, Sung understands the concerns international manufacturers and distributors have when attempting to market their products in the United States.
Experience
Representative matters
Experience
Recognitions
Ranked in Chambers USA for Nationwide Food & Beverages: Regulatory & Litigation, 2024-2026
Ranked in Chambers USA for District of Columbia Healthcare: Pharmaceutical/Medical Products Regulatory, 2025-2026
Credentials
Education
- The George Washington University Law School, 2014, J.D.
- University of Wisconsin - Madison, 2010, B.S., Biology
Professional admissions & qualifications
- Virginia
- Washington, D.C.